indiamed
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
  • News
  • Opinion
  • Interviews
  • IT
  • Finance
  • Strategy
    • Innovation
  • Magazine
facebook x icon x icon linkedin linkedin
all-news

CARI, Kolkata and SNPS, Jadavpur University in MoU on ayurvedic formulation for diabetes mgmt

IMT News Desk

To evaluate the potential of ayurvedic formulation Vidangadi Lauham for diabetes

In a significant step towards advancing Ayurveda research in diabetes management, the Central Ayurveda Research Institute (CARI), Kolkata, under the Central Council for Research in Ayurvedic Sciences (CCRAS) Ministry of Ayush, has signed a Memorandum of Understanding (MoU) with the School of Natural Product Studies (SNPS), Jadavpur University, Kolkata. The agreement, formalised at CARI, Kolkata, marks the beginning of a collaborative research project titled 'Evaluation of Vidangadi Lauham, a Classical Ayurvedic Formulation in the Management of Diabetes in Experimental Animals.'

This research project holds immense potential in the field of Ayurveda research, aiming to establish a strong scientific foundation for the use of Vidangadi Lauham in diabetes management. By conducting biophysical characterisation and analysing the biological activity of medicinal plants, the study will contribute significantly to the preservation and restoration of India’s rich medicinal plant heritage. The findings will be instrumental in developing high-quality, safe, and effective Ayurvedic formulations for combating diabetes and its complications.

Furthermore, the project highlights the need for a comprehensive database to validate the health benefits of medicinal plants, ensuring their credibility in the global healthcare landscape. The ultimate goal is to popularise Ayurvedic formulations as natural health-promoting agents, fostering greater acceptance of traditional medicine worldwide. With diabetes being a growing global concern, this research initiative has the potential to lead to the development of an Ayurvedic formulation with minimal to no side effects, ultimately improving public health and enhancing the quality of life for countless individuals.

The MoU signing ceremony was attended by officials from both institutions, including Dr. G. Babu, Director, CARI, Kolkata, alongside Dr Anupam Mangal, Assistant Director (Pharmacognosy), Dr Lalrin Puia, Research Officer (Pharmacology), Dr Sharad D Pawar, Assistant Director (Pharmacology), and Dr Rahul Singh, Research Officer (AEP). Representing SNPS, Jadavpur University, Prof (Dr) Pallab Kanti Halder, Director and Principal Investigator of the project, was also present.

Recommended

Glenmark registers consolidated revenue of Rs 60,469 Mn in Q2FY26

Delhi to host 18th edition of CPHI & PMEC India 2025 from Nov 25 to 27, 2025

Pathkind and WebEngage unite to deliver personalised, data-driven patient experiences

Akums reports consolidated revenue of Rs 1,018 crore in Q2 FY26

Apollo Cancer Centre unveils cellular therapy and blood and marrow transplant centre in Bengaluru

Hester Biosciences posts consolidated net profit of Rs 14.33 Cr for Q2 FY25-26

ENTOD launches LUBRINASE for nasal dryness

OMRON Healthcare announces additional investment in India-based AI medtech startup Tricog Health India

Indiamedtoday

A premier media platform empowering healthcare professionals with critical business insights, news, and innovations to excel in a rapidly evolving industry.

EMAIL editorial@indiamedtoday.com

EMAIL sales@indiamedtoday.com

quick links

news health it interview opinion strategy magazine privacy policy terms and conditions

subscribe to our newsletter

Stay updated with the latest breakthroughs in Indian healthcare, medical research, and wellness insights.

    follow us

    facebook x icon x icon linkedin linkedin
    Copyright © 2025 INDIAMED TODAY Marketed By Screetract Solutions